Portfolio company
Enveda
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
5 investors
Sectors
About
This biotechnology company develops pharmaceutical drug candidates for patients with inflammatory and metabolic diseases using an artificial intelligence platform to decode plant chemistry.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Enveda Bioscience
This company develops small molecule medicines for patients with inflammatory and metabolic diseases by using machine learning to map natural plant chemistry.
Metaphore Biotechnologies
This biotechnology company develops an artificial intelligence platform to design functional antibody medicines for pharmaceutical partners and patients with autoimmune, metabolic or oncology conditions.
Envisagenics
This biotechnology company develops an artificial intelligence platform to identify drug targets from RNA splicing data for pharmaceutical and biopharmaceutical organisations.
Technology-enabled pharmaceutical company
This company develops small molecule drug candidates using artificial intelligence for the pharmaceutical and biotechnology industries.
Dewpoint Therapeutics
This biotechnology company develops condensate-modifying small molecule drugs for patients with oncology, neurodegenerative, cardiopulmonary and metabolic diseases using an AI-enabled discovery platform.
innovothera
This biotechnology company develops small-molecule therapies for fibrosis, inflammatory diseases, and cancer using an artificial intelligence drug discovery platform.
PharmEnable
This company develops small molecule medicines using an artificial intelligence platform for pharmaceutical partners and patients with oncology and neurology conditions.
Cyanotype Bio
The company develops an artificial intelligence platform for discovering and manufacturing plant-based bioactives for the biotechnology and environmental research industries.
